Imbioray

Imbioray is a biotechnology company that specializes in cellular immunotherapy for tumors and immune diseases.

Active

Updated: Feb 17, 2026 ·

About

Imbioray is a biotechnology company dedicated to the field of cellular immunotherapy. Its core focus lies in developing innovative treatments designed to address both tumors and immune diseases. This specialization positions the company within a critical and rapidly advancing sector of medical science, aiming to harness the body's own immune system for therapeutic benefit.

Recent News & Mentions

Feb 5, 2026FundingImbioray - Series B

Financial History

Imbioray has raised $28.8M across 1 funding round. Most recently, it raised $28.8M Series B in February 2026.

Total Raised

$28.8M

Valuation

N/A

Funding Rounds Raised

Date	Round	Lead Investors	Other Investors
Feb 5, 2026	$28.8M Series B	Deep Intelligent Pharma	Hainan Yuque Investment, Hangzhou Xiner Technology, Shen Yousheng

Financial History

Imbioray has raised $28.8M across 1 funding round.

Total Raised

$28.8M

Valuation

N/A

Deep Dive

The company's primary activities encompass the research and development of these advanced cellular immunotherapies. This involves a comprehensive approach to creating new therapeutic solutions, from initial scientific inquiry to potential clinical applications, all centered on improving patient outcomes for complex conditions.

Operating as a privately held organization, Imbioray maintains its independence in strategic direction and operational execution. This ownership structure supports its long-term commitment to its specialized research areas. The company previously operated under the corporate identity of Hangzhou Yingbairui Biomedical Technology Co., Ltd., indicating a historical evolution in its legal or brand presence.

Imbioray is headquartered in Hangzhou, Zhejiang, China. This location serves as the central hub for its research, development, and administrative functions, contributing to the regional biotechnology ecosystem. The company's presence in Hangzhou underscores its role in the broader landscape of biopharmaceutical innovation.

Sources

Frequently Asked Questions

Where is Imbioray headquartered?

Imbioray's headquarters are located in Hangzhou, Zhejiang, China.

What was Imbioray's previous corporate identity?

Imbioray was formerly known as Hangzhou Yingbairui Biomedical Technology Co., Ltd.